Neurogene Inc.
Neurogene develops gene therapies for neurological diseases using proprietary EXACT transgene regulation technology.
SCHEDULE 13G/ANov 16Latest SEC filing
Nov 17Latest story
November 2026
August 2026
July 2026
June 2026
Neurogene develops gene therapies for neurological diseases using proprietary EXACT transgene regulation technology.
November 2026
August 2026
July 2026
June 2026